Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

Clinical trial NCT01129544 · COMPLETED

Trial details

NCT number: NCT01129544
Sponsor: David Williams
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Combined Immunodeficiency

Start date: 2010-04-01
Primary completion: 2023-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.